CenterBook Partners LP Boosts Stock Position in Stevanato Group S.p.A. $STVN

CenterBook Partners LP lifted its position in Stevanato Group S.p.A. (NYSE:STVN) by 304.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 249,510 shares of the company’s stock after acquiring an additional 187,752 shares during the quarter. CenterBook Partners LP owned 0.08% of Stevanato Group worth $5,020,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in STVN. Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in shares of Stevanato Group in the 4th quarter worth approximately $9,269,000. Norges Bank acquired a new position in shares of Stevanato Group in the 4th quarter worth approximately $8,185,000. Credit Agricole S A acquired a new position in shares of Stevanato Group in the 3rd quarter worth approximately $9,785,000. TimesSquare Capital Management LLC grew its position in shares of Stevanato Group by 7.1% in the 4th quarter. TimesSquare Capital Management LLC now owns 3,500,321 shares of the company’s stock worth $70,426,000 after acquiring an additional 232,645 shares in the last quarter. Finally, Jennison Associates LLC grew its position in shares of Stevanato Group by 13.7% in the 4th quarter. Jennison Associates LLC now owns 1,772,896 shares of the company’s stock worth $35,671,000 after acquiring an additional 213,602 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on STVN. KeyCorp decreased their target price on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, March 5th. Wolfe Research began coverage on Stevanato Group in a research report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 target price for the company. Morgan Stanley decreased their target price on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, March 6th. Wall Street Zen lowered Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. Finally, Jefferies Financial Group set a $17.50 target price on Stevanato Group in a research report on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Stevanato Group Trading Up 0.7%

NYSE:STVN opened at €18.58 on Monday. Stevanato Group S.p.A. has a 12-month low of €12.89 and a 12-month high of €28.00. The firm has a market capitalization of $5.63 billion, a P/E ratio of 31.49, a P/E/G ratio of 1.70 and a beta of 0.78. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.63 and a quick ratio of 1.11. The business has a 50 day simple moving average of €16.40 and a 200 day simple moving average of €17.77.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The company had revenue of €273.57 million for the quarter. During the same period in the prior year, the company earned $0.10 EPS. Stevanato Group’s revenue for the quarter was up 6.6% on a year-over-year basis. Equities research analysts predict that Stevanato Group S.p.A. will post 0.68 EPS for the current year.

Stevanato Group Cuts Dividend

The business also recently disclosed an annual dividend, which will be paid on Wednesday, July 29th. Investors of record on Thursday, June 11th will be given a dividend of $0.054 per share. The ex-dividend date is Thursday, June 11th. This represents a yield of 29.0%.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.